Gene therapy: X-SCID transgene leukaemogenicity (Q34567588)

3 August 2017

Gene therapy: X-SCID transgene leukaemogenicity (English)

1 reference

3 August 2017

0 references

15

0 references

Marina Cavazzana

14

Marina Cavazzana-Calvo

0 references

Salima Hacein-Bey-Abina

13

Salima Hacein-Bey Abina

0 references

Axel Schambach

5

Axel Schambach

0 references

Makoto Otsu

Makoto Otsu

7

0 references

Karen Blyth

Karen Blyth

11

0 references

Adrian Thrasher

Adrian J Thrasher

1

0 references

Ute Modlich

4

Ute Modlich

1 reference

3 August 2017

2

H Bobby Gaspar

1 reference

3 August 2017

Christopher Baum

3

1 reference

3 August 2017

Fabio Candotti

6

1 reference

3 August 2017

Brian Sorrentino

8

1 reference

3 August 2017

Linda Scobie

9

1 reference

3 August 2017

Ewan Cameron

10

1 reference

3 August 2017

Jim Neil

12

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 September 2006

1 reference

3 August 2017

1 reference

3 August 2017

443

1 reference

3 August 2017

E5-6; discussion E6-7

1 reference

3 August 2017

7109

1 reference

https://scigraph.springernature.com/pub.10.1038/nature05219

3 August 2017

0 references

cites work

Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05219

Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05219

Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05219

A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05219

Gene therapy: therapeutic gene causing lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05219

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05219

Gene therapy insertional mutagenesis insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05219

Leukemias following retroviral transfer of multidrug resistance 1 (MDR1) are driven by combinatorial insertional mutagenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05219

Lymphoid development and function in X-linked severe combined immunodeficiency mice after stem cell gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05219

21 January 2018

Identifiers

DOI

10.1038/NATURE05219

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference